chr17-75752221-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000213.5(ITGB4):c.3841C>T(p.Arg1281Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1281P) has been classified as Pathogenic.
Frequency
Consequence
NM_000213.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITGB4 | NM_000213.5 | c.3841C>T | p.Arg1281Trp | missense_variant | 31/40 | ENST00000200181.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITGB4 | ENST00000200181.8 | c.3841C>T | p.Arg1281Trp | missense_variant | 31/40 | 1 | NM_000213.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251360Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135884
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461562Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727086
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2019 | The R1281W variant has been published previously in the homozygous state and with another ITGB4 variant in patiens with JEB-PA (Pulkkinen et al., 1998; Kambham et al., 2000) . It was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry by the NHLBI Exome Sequencing Project. R1281W is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the second fibronectin type III domain that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant at the same residue (R1281P) has been reported in the Human Gene Mutation Database in association with epidermolysis bullosa with pyloric atresia (Stenson et al., 2014), supporting the functional importance of this region of the protein. Functional studies of the R1281W variant have shown that it abrogates interaction with plectin, resulting in lack of recruitment at the plasma membrane and abolished tumor-suppressive function (Koster et al., 2001; Raymond et al., 2007). Therefore, we consider the R1281W variant to be pathogenic. - |
Junctional epidermolysis bullosa with pyloric atresia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2001 | - - |
Junctional epidermolysis bullosa Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 26, 2024 | Variant summary: ITGB4 c.3841C>T (p.Arg1281Trp) results in a non-conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251360 control chromosomes. c.3841C>T has been reported in the literature in individuals affected with Junctional Epidermolysis Bullosa (example: Pulkkinen_1998). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence showing that this variant prevents the recruitment of plectin into hemidesmosomes in COS-7 cells and abolishes the interaction with plectin in yeast (Koster_2001). The following publications have been ascertained in the context of this evaluation (PMID: 11886501, 9792864). ClinVar contains an entry for this variant (Variation ID: 14742). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at